MGC Pharmaceuticals Limited NPV (DI) (MXC) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Jul 2023 07:00 AM
RNS
Reclassification of Psychedelic Compounds
30 Jun 2023 09:31 AM
RNS
Details of Company Address
30 Jun 2023 09:30 AM
RNS
Company Update
29 Jun 2023 10:22 AM
RNS
Results of Shareholder’s General Meeting
01 Jun 2023 07:30 AM
RNS
Appointment of Non-Executive Director
31 May 2023 07:00 AM
RNS
First CannEpil® delivered to UK patients
30 May 2023 07:01 AM
RNS
Corporate Update - Board and UK Adviser Changes
30 May 2023 07:00 AM
RNS
Dispatch of General Meeting Documents
18 May 2023 12:00 PM
RNS
Director/PDMR Shareholding
10 May 2023 05:05 PM
RNS
Director/PDMR Shareholding
02 May 2023 07:00 AM
RNS
Malta Production Facility Receives EU-GMP Approval
28 Apr 2023 07:13 AM
RNS
March 2023 Quarterly Activities and Cash Flow
13 Apr 2023 07:00 AM
RNS
Fundraise closed raising a total of £2,090,890
11 Apr 2023 07:01 AM
RNS
£1.2 million raised in a conditional Placing
11 Apr 2023 07:00 AM
RNS
CannEpil® available by Named Patient Request in UK
03 Apr 2023 07:00 AM
RNS
Approval to Develop and Research with Psilocybin
21 Mar 2023 09:05 AM
RNS
Second Price Monitoring Extn
21 Mar 2023 09:00 AM
RNS
Price Monitoring Extension
21 Mar 2023 07:00 AM
RNS
ArtemiC Listed as OTC Drug; AMC Places US$2m order
15 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
15 Mar 2023 07:00 AM
RNS
First patient enrolled in MGC ZAM App
08 Mar 2023 09:00 AM
RNS
US$500,000 funding received under Mercer Facility
07 Mar 2023 07:00 AM
RNS
Completion of CimetrAT Mechanism of Action study
01 Mar 2023 07:02 AM
RNS
Appointment of UK Lead Broker and Change of Co Sec
28 Feb 2023 09:08 AM
RNS
Half-year Report
10 Feb 2023 08:45 AM
RNS
Updated Investor Presentation
03 Feb 2023 07:00 AM
RNS
Provision of US$600,000 funding and change of CFO
02 Feb 2023 07:00 AM
RNS
Extension of Convertible Securities Agreements
30 Jan 2023 07:00 AM
RNS
December 2022 Quarterly Activities and Cash Flow
23 Jan 2023 04:40 PM
RNS
Second Price Monitoring Extn
23 Jan 2023 04:35 PM
RNS
Price Monitoring Extension
16 Jan 2023 07:00 AM
RNS
Change of Adviser - SW4 Partners
11 Jan 2023 09:01 AM
RNS
Change in External Financial Auditor
10 Jan 2023 07:00 AM
RNS
Completion of CimetrAT Pre-clinical Trial
03 Jan 2023 07:00 AM
RNS
Internal Costs Review Completed and Board Change
28 Dec 2022 09:10 AM
RNS
A$800,000 funding received under Mercer Facility
08 Dec 2022 01:46 PM
EQS
MGC Pharmaceuticals delivers its largest-ever o...
07 Dec 2022 07:00 AM
RNS
Completion of CimetrA Efficacy Pre-clinical Trial
05 Dec 2022 07:00 AM
RNS
Delivery of US$1m order of ArtemiC to AMC Holdings
02 Dec 2022 07:00 AM
RNS
Publication of MGC Pharma Glioblastoma research
28 Nov 2022 07:00 AM
RNS
Result of AGM and Investor Presentation
22 Nov 2022 07:00 AM
RNS
Website Update
16 Nov 2022 09:00 AM
RNS
Notice of AGM
09 Nov 2022 10:20 AM
RNS
Application for Admission to Trading
31 Oct 2022 07:00 AM
RNS
September Quarterly Activities and Cash Flow
25 Oct 2022 07:00 AM
RNS
ArtemiC Support - Long COVID Clinical Study Resuls
20 Oct 2022 07:00 AM
RNS
Operations Update - Major Milestones Achieved
18 Oct 2022 09:00 AM
RNS
2022 AGM Notice of Meeting and Annual Report
05 Oct 2022 01:03 PM
RNS
Results of Shareholder's General Meeting
04 Oct 2022 07:00 AM
RNS
Appointment of UK Advisor and Company Update
UK 100

Latest directors dealings